Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97682203 | 9768220 | 3 | F | 20150429 | 20131217 | 20160714 | EXP | GB-BRISTOL-MYERS SQUIBB COMPANY-19923630 | BRISTOL MYERS SQUIBB | 47.00 | YR | M | Y | 0.00000 | 20160714 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97682203 | 9768220 | 1 | PS | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | Intra-arterial | 40 MG, UNK | U | 12041 | 40 | MG | SUSPENSION FOR INJECTION | ||||||
| 97682203 | 9768220 | 2 | I | RITONAVIR. | RITONAVIR | 1 | Unknown | U | 0 | ||||||||||
| 97682203 | 9768220 | 3 | C | LOPINAVIR | LOPINAVIR | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97682203 | 9768220 | 1 | Product used for unknown indication |
| 97682203 | 9768220 | 2 | Antiretroviral therapy |
| 97682203 | 9768220 | 3 | Antiretroviral therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97682203 | 9768220 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97682203 | 9768220 | Adrenal suppression | |
| 97682203 | 9768220 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |